Veterinary Vaccines Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Veterinary vaccines market
Veterinary Vaccines Market: By Type (Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines, Others) Type of Disease (Bovine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines, Equine Vaccines)-Forecast (2018 - 2023)
Report Code : HCR 0058
Updated Date: 23 October, 2018  
5

Copies sold

    Client Rating

1. Veterinary Vaccines Market - Overview
1.1. Definitions and Scope
2. Veterinary Vaccines Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Veterinary Vaccines Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Veterinary Vaccines Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Veterinary Vaccines Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Veterinary Vaccines Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Veterinary Vaccines Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Veterinary Vaccines Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Veterinary Viral Vaccines
8.3.1.1. Live Viral Vaccines
8.3.1.2. Inactivated Viral Vaccines
8.3.1.3. DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
8.3.1.4. Molecularly Defined Subunit Vaccines
8.3.1.5. Genetically Engineered Viral Vaccines
8.3.1.6. Live Viral Vector Vaccines
8.3.1.7. DNA Vaccines
8.3.2. Veterinary Bacterial Vaccines
8.3.2.1. Conventional Live Vaccines
8.3.2.2. Conventional Inactivated Vaccines
8.3.2.3. Gene-Deleted Vaccines
8.3.2.4. Subunit Vaccines
8.3.3. Veterinary Parasite Vaccines
8.3.3.1. Protozoal Vaccines
8.3.3.2. Subunit Protozoal Parasite Vaccines
8.3.3.3. Helminth and Ectoparasite Vaccines
8.3.4. Veterinary Vaccines for Infectious Diseases
8.3.4.1. Allergy Vaccines
8.3.4.2. Allergy Vaccines
9. Veterinary Vaccines Market – By Type of Disease (Market Size -$Million / $Billion)
9.1. Bovine Vaccines
9.1.1. Bovine Viral Diarrhea
9.1.2. Brucellosis
9.1.3. Foot and mouth disease
9.1.4. Bovine Clostridial disease
9.1.5. Infectious Bovine Rhinotracheitis
9.2. Porcine Vaccines
9.2.1. Porcine Parvovirus
9.2.2. Porcine Reproductive Respiratory Syndrome
9.2.3. Porcine Circovirus II
9.2.4. Swine Influenza
9.2.5. Auzeszky’s Diseases
9.2.6. Swine Pneumonia
9.3. Feline Vaccines
9.3.1. Feline Rabies
9.3.2. Feline Panleukopenia
9.3.3. Feline Leukemia
9.4. Canine Vaccines
9.4.1. Canine Rabies
9.4.2. Canine Distemper
9.4.3. Canine Parvovirus
9.5. Poultry Vaccines
9.5.1. Infectious Bronchitis
9.5.2. Gumboro disease
9.5.3. Avian Influenza
9.5.4. Coccidiosis
9.5.5. Mycoplasma
9.5.6. Newcastle disease
9.5.7. Marek’s disease
9.6. Equine Vaccines
9.6.1. Strangles
9.6.2. Equine Influenza
9.6.3. Equine Encephalomyelitis
9.6.4. Tetanus
9.6.5. Equine Rhinopneumonitis
10. Veterinary Vaccines - By Geography (Market Size -$Million / $Billion)
10.1. Veterinary Vaccines Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Veterinary Vaccines - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Veterinary Vaccines - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Veterinary Vaccines – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Veterinary Vaccines Market - Entropy
11.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships
12. Veterinary Vaccines Market – Industry / Segment Competition landscape
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Veterinary Vaccines Market – Key Company List by Country
14. Veterinary Vaccines Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Bayer Healthcare
14.3. Bioniche Animal Health
14.4. Biogenesis Bago SA
14.5. Elanco Animal Health
14.6. Embrex Inc.
14.7. Fort Dodge Animal Health
14.8. Heska Corporation
14.9. Imugene Limited
14.10. Lohmann Animal Health
14.11. Merck Animal Healthcare
14.12. Merial Inc.
14.13. Virbac Corporation
14.14. Company 13
14.14. Company 14 
15.16. Company 15 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Veterinary Vaccines Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Veterinary Vaccines Market -Methodology
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll